Sotrovimab in pediatric cardiac transplant recipients with SARS-CoV2 infection

J Heart Lung Transplant. 2022 Aug;41(8):1124-1126. doi: 10.1016/j.healun.2022.05.003. Epub 2022 May 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neutralizing
  • COVID-19*
  • Child
  • Heart Transplantation*
  • Humans
  • RNA, Viral
  • SARS-CoV-2
  • Transplant Recipients

Substances

  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neutralizing
  • RNA, Viral
  • sotrovimab